n Cardiovascular Journal of South Africa - VALIANT trial results support use of valsartan in acute myocardial infarction : drug trends in cardiology

Volume 15, Issue 1
  • ISSN : 1680-0745



Extracted from text ... 45 The Valsartan in Acute Myocardial Infarction (VALIANT) study results, announced last week at the American Heart Association Meeting, confirmed the value of using valsartan (Diovan(r)) in early post-MI heart failure or left ventricular dysfunction, while also adding additional pharmacological insights into this acute cardiac condition.1, 2 The VALIANT trial that started in 2000 compared the effects of the angiotensin receptor blocker valsartan, the ACE inhibitor captopril, and the combination of valsartan and captopril, in a population of high-risk patients with clinical or radiological evidence of heart failure, evidence of left ventricular systolic dysfunction, or both, after acute myocardial infarction. ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error